Debunked · 8 min read · Updated March 2026

GcMAF: The Retracted Fraud That Still Exploits Cancer Patients

Three of four foundational papers retracted for fabricated data. The main seller jailed for 15 months and fined millions. Yet GcMAF products are still sold online to desperate cancer patients. This is a story about the cost of scientific fraud.

❌ DEBUNKED: Retracted Research / Fraud

The Bottom Line

Do not buy or use GcMAF products. The entire evidence base for GcMAF as a cancer treatment rests on research by Nobuto Yamamoto, of which three out of four papers were retracted by their journals in 2014 for fabricated institutional review board approvals, fictitious research groups, and serious methodological irregularities. The primary commercial seller, David Noakes (Immuno Biotech), was jailed for 15 months in 2018 and fined for manufacturing and selling unlicensed medicines that were found unsuitable for human use. Products sold online today are unregulated, of unknown composition, and potentially dangerous.

What GcMAF Supposedly Is

GcMAF stands for Gc protein-derived Macrophage Activating Factor. The theory is:

  1. Gc protein (also called vitamin D-binding protein, or VDBP) is a normal blood protein
  2. Yamamoto claimed that cancer cells produce an enzyme called nagalase, which deactivates Gc protein and suppresses the immune system
  3. GcMAF is supposedly a modified version of Gc protein that reactivates macrophages (immune cells) to attack cancer
  4. Yamamoto published papers claiming 100% cure rates in breast, colorectal, and prostate cancer patients

The mechanism description sounds plausible at a surface level. That's what made it so effective as a scam.

The Retracted Papers

Yamamoto published four key papers between 2007 and 2009:

  • Breast cancer paper (2008) in International Journal of Cancer: RETRACTED in 2014
  • Colorectal cancer paper (2008) in Cancer Immunology, Immunotherapy: RETRACTED in 2014
  • Prostate cancer paper (2009): RETRACTED in 2014
  • HIV paper (2009): RETRACTED

The retraction reasons, as documented by Retraction Watch and the journals themselves:

  • Fabricated ethics approvals: The "Nagasaki Immunotherapy Research Group" and "Hyogo Immunotherapy Research Group" that supposedly approved Yamamoto's trials do not exist. They appear nowhere outside his papers.
  • People listed as members denied involvement: Three individuals named in the IRB approval documents stated they were never part of these groups and never participated in Yamamoto's research.
  • Purported sponsors denied involvement: Organizations listed as trial sponsors denied having supported GcMAF clinical research.
  • Impossibly perfect results: Yamamoto claimed 100% response rates across multiple cancer types, a result virtually never seen in oncology.

As the Anticancer Fund stated: these retracted papers were "used as foundational texts by sophisticated fraudsters selling fake cures for cancer, autism, and HIV."

The Criminal Prosecution

David Noakes, a UK businessman with no medical qualifications, founded Immuno Biotech and built a GcMAF empire:

  • He manufactured GcMAF in unlicensed facilities and sold it worldwide
  • His company generated an estimated £7.9 million in revenue
  • The UK's MHRA (Medicines and Healthcare products Regulatory Agency) seized his products and found them unsuitable for human use
  • In 2018, Noakes pled guilty to manufacturing, selling, and supplying an unlicensed medicine, plus money laundering
  • He was sentenced to 15 months in prison (12 for medicine offenses, 3 for money laundering)
  • The BMJ, Medscape, and multiple news outlets covered the sentencing

Why People Still Believe

Despite the retractions and criminal conviction, GcMAF products are still sold online and promoted in alternative medicine circles. Several factors keep the myth alive:

  • Conspiracy framing: Advocates claim the retractions and prosecution prove GcMAF "works" because the establishment is trying to suppress it. This is an unfalsifiable argument: evidence against GcMAF becomes evidence of a coverup.
  • The nagalase hook: Nagalase is a real enzyme. The idea that "cancer produces nagalase to hide from your immune system" sounds scientifically plausible to non-experts. But nagalase as a cancer biomarker has never been validated by any major oncology organization.
  • Desperate patients: People with terminal diagnoses are vulnerable to hope, especially when conventional medicine has run out of options. GcMAF sellers exploit this vulnerability.
  • The Bradstreet connection: Dr. James Bradstreet, who promoted GcMAF for autism, was found dead in a river in 2015 shortly after an FDA raid on his clinic. His death fueled conspiracy theories, though it was ruled a suicide.

Is There Any Legitimate Science?

The concept of macrophage activation factor is not inherently fraudulent. VDBP/Gc protein is a real molecule, and macrophage activation is a real immunological process. The problem is specific to Yamamoto's clinical claims:

  • No independent group has ever replicated Yamamoto's clinical results
  • The preclinical work has some basis, but has not led to legitimate clinical development
  • CHIPSA Hospital in Mexico continues to offer GcMAF-related treatments, but without published peer-reviewed clinical trial data
  • Any potential that the underlying biology once held has been thoroughly contaminated by fraud, making legitimate researchers unwilling to touch it

The Lesson

GcMAF is a case study in how scientific fraud causes lasting harm:

  • Retracted papers don't disappear. They're still cited, shared on social media, and used to sell products. The internet's memory outlasts journal corrections.
  • 100% cure rate claims are always a red flag. Cancer is biologically complex. No treatment works on 100% of patients. Not chemotherapy, not immunotherapy, not surgery. If someone claims a 100% cure rate, they're lying or their data is fabricated.
  • Unregulated injectable products are dangerous. GcMAF products sold online are manufactured without pharmaceutical oversight. You don't know what's in them, how they were stored, or whether they're sterile.

Sources

  • Wikipedia: GcMAF (comprehensive overview with retraction details) wikipedia.org
  • Retraction Watch (2014): "Paper about widely touted but unapproved cure for cancer retracted" retractionwatch.com
  • BMJ 2018;363:k5042: "Boss who made £7.9m from selling fake cancer cure is jailed" bmj.com
  • Medscape (2019): "UK Multimillionaire Jailed for Peddling Fake Cancer Cure" medscape.com
  • Anticancer Fund: "Cancer patients should be aware of scientific misinformation" anticancerfund.org
  • Medika Life (2021): "GcMAF, a Cancer Cure Con That Just Refuses to Die" medika.life

Related Research

Safety Warning: GcMAF products sold online are unregulated and of unknown composition. The foundational research was retracted for fraud. The primary seller was criminally convicted. Do not purchase or use GcMAF products. If you encounter GcMAF being sold or recommended, report it to your country's medicines regulatory agency.

How we grade evidence: Grade A = Phase II+ RCT with positive signal. Grade B = Phase I/II or strong epidemiology. Grade C = Preclinical only. Debunked = Retracted or disproven. Full methodology →